Dirk Thye - CEO and CMO, Director at Quince Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and CMO, Director
Issuer Symbol
QNCX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Dirk Thye since 11 Mar 2025

Holdings reported by Dirk Thye for Quince Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 739,885 $1,243,006 $1.68 10 Dec 2025 Thye Trust
Common Shares 255,000 $428,400 $1.68 10 Dec 2025 Direct
Warrants 150,944 $18,868 $0.1250 18 Jun 2025 Direct Common Shares
Employee Stock Option (Right to Buy) 1,000,000 23 Jan 2026 Direct Common Shares

Transactions reported by Dirk Thye for Quince Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.